DTE vs VIVS
DTE (DTE) versus VivoSim Labs, Inc. (VIVS) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
DTE currently screens at market cap $0. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
Not investment advice. Open the DTE and VIVS stock pages for the full models.
Not investment advice.